Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids

Thorax

Volumn 52, Issue 5, 1997, Pages 476-482

  Lipworth, B J ^a   Seckl, J R ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; HYDROCORTISONE; OSTEOCALCIN; TETRACOSACTIDE;

BONE METABOLISM; BONE MINERAL; CHILD GROWTH; CORTICOSTEROID THERAPY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG MONITORING; HUMAN; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW;

EID: 0030925660     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.5.476     Document Type: Review

References (49)

1. Lipworth BJ. Airway and systemic effects of inhaled corticosteroids in asthma: dose response relationship. Pulm Pharmacol 1996;9:19-27.
2. Lipworth BJ. New perspectives on inhaled drug delivery and systemic bioactivity. Thorax 1995;50:105-10.
3. Lipworth BJ. Pharmacokinetics of inhaled drugs. Br J Clin Pharmacol 1996;42:697-705.
4. Barnes NC, Marone G, Di Maria GV, Visser S, Utama I, Payne SI. A comparison of fluticasone propionate 1 mg daily with beclomethasone dipropionate 2 mg daily in the treatment of severe asthma. Eur Respir J 1993;6:877-84.
5. Fabbri L, Burge PS, Croonenburgh L, Warlies F, Weeke B, Ciaccia A, et al. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. Thorax 1993;48:817-33.
6. Lundback B, Alexander M, Day J, Herbert J, Holzer R, Van Uffelen R, et al. Evaluation of fluticasone propionate (500 mg/day) administered either as dry powder via a diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 μg/day) administered by pressurized inhaler. Respir Med 1993;87:609-20.
7. Ayres JG, Bateman ED, Lundback B, Harris TAJ. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6mg daily, in patients with chronic severe asthma. Eur Respir J 1995;8: 579-86.
8. Grahnen A, Eckernas SA, Brundin RM, Ling-Andersson A. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers. Br J Clin Pharmacol 1994;38:521-5.
9. Lonnebo A, Grahnen A, Jansson B, Brunden RM, Ling-Andersson A. An assessment of the systemic effects of single repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers. Eur J Clin Pharmacol 1996;49:459-63.
10. Brown PH, Bludell G, Greening AP, Crompton GK. Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high doses of inhaled corticosteroid. Respir Med 1991;85:511-6.
11. McIntyre DH, Mitchell CA, Bowler SD, Armstrong JG, Wooler JA, Cowlie DM. Measuring the systemic effects of inhaled beclomethasone: timed morning urine collections compared with 24 hour specimens. Thorax 1995;51:281-4.
12. Clark DJ, Lipworth BJ. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients. Thorax 1997;52:55-8.
13. Clark DJ, Clark RA, Lipworth BJ. Adrenal suppression with inhaled budesonide and fluticasone propionate given by a large volume spacer to asthmatic children. Thorax 1996; 51:941-3.
14. Pedersen S, Steffensen G, Ekman I, Tonnesson M, Borga O. Pharmacokinetics of budesonide in children with asthma. Eur J Clin Pharmacol 1987;31:579-82.
15. Priftis K, Milner AD, Conway E, Honor JW. Adrenal function in asthma. Arch Dis Child 1990;65:838-40.
16. Crowley S, Hindmarsh PC, Holownia P, Honor JW, Brook CGD. The use of low doses of ACTH in the investigation of adrenal function in man. J Endocrinol 1991;130:475-9.
17. Rasmuson S, Olsson T, Hagg E. A low dose ACTH test to access the function of the hypothalamic-pituitary-adrenal adrenal axis. Clin Endocrinol 1996;44:151-6.
18. Crowley S, Hindmarsh PC, Honor JW, Brook CGD. Reproducibility of the cortisol response to simulation with a low dose of ACTH (1-24): the effect of basal cortisol levels in comparison of low dose with high dose secretory dynamics. J Endocrinol 1993;136:167-72.
19. Broide J, Soferman R, Kivity S, Golander A, Dickstein G, Spirer Z, Weisman Y. Low dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab 1995;80:1243 6.
20. Schlanghecke R, Kornely E, Santen R, Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin releasing hormone. N Engl J Med 1992;326:226 30.
21. Clark DJ, Lipworth BJ. Evaluation of corticotropin releasing factor stimulation and basal markers of HPA-axis suppression in asthmatic patients. Br J Clin Pharmacol 1997; 43:206.
22. Knutsson U, Stiema P, Marcus C, Carlstedt-Duke J, Carlstrom K, Bronnegrd M. Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function. J Endocrinol 1995;144:301-10.
23. Knutsson PU, Bronnegard M, Marcus C, Stierna P. Regulation of glucocorticoid receptor mRNA in nasal mucosa by local administration of fluticasone and budesonide. J Allergy Clin Immunol 1996;97:655-61.
24. Boe J, Bakke P, Rodolen T, Skovlund E, Gulsvik A. High dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Eur Respir J 1994;7:2179 84.
25. Birkebaek NH, Esberg G, Andersen K, Wolthers O, Hassager C. Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate. Arch Dis Child 1995;73:524-7.
26. Sorva R, Turpeinen M, Jnutunen-Backman K, Karnonen S, Sorva A. Effect of inhaled budesonide on serum markers of bone metabolism in children with asthma. J Allergy Clin Imunol 1992;9:808-15.
27. Bootsma GP, Dekhuijzen R, Festen J, Mulder PGH, Swinkels LMJW, van Herwaarden CLA. Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate. Am J Respir Crit Care Med 1996;153:924-30.
28. Grove A, McFarlane LC, Jackson CM, Lipworth BJ. Effects of short-term exposure to high dose inhaled corticosteroids on novel markers of bone metabolism. Eur J Clin Phamacol 1996;5:275-7.
29. Kirstjens HAM, Postma DS, van Dormaal JJ, van Zanten AK, Brand BLP, Dekhuijzen RNP, et al. Effect of short and long term treatment with inhaled corticosteroids on bone metabolism patients with airway obstruction. Thorax 1994;49:652-6.
30. Hanania NA, Chapman KR, Sturtridge WC, Szalii JP, Kesten S. Dose related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 1995;96:571-9.
31. Toogood JH, Baskerville JC, Markov AE, Hodesman AB, Frarher LG, Jennings B, et al. Bone mineral density and the risk of fracture in patients receiving long term inhaled steroid therapy for asthma. J Allergy Clin Immunol 1995; 96:157-66.
32. Braraldi E, Bollini MC, Demarchi A, Zacchello F. Effect of beclomethasone dipropionate on bone mineral content assessed by X-ray densitometry in asthmatic chidren: a longitudinal evaluation. Eur Respir J 1994;7:710-4.
33. Martinati B, Bertoldo F, Gasperi E, Micelli S, Boner AL. Effect on cortical and trabecular bone mass of different anti-inflammatory treatments in preadolescent children with chronic asthma. Am J Respir Crit Care Med 1996; 153:232-6.
34. Lipworth BJ, Clark DJ. High dose inhaled steroids in asthmatic children. Lancet 1996;348:820.
35. Edsbacker S, Andersson KE, Ryrfeldt A. Nasal bioavailability and systemic effects of the glucocorticoid budesonide in man. Eur J Clin Pharmacol 1985;29:477 81.
36. Foresi A, Pelucchi A, Gherson G, Mastropasqua B, Chiapparino A, Testi R. Once daily intranasal fluticasone propionate (200 μg) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 1996;98:274-82.
37. Wolthers OD, Pedersen S. Measures of systemic activity of inhaled corticosteroids in children: a comparison of urine cortisol excretion and knemometry. Respir Med 1996;89: 347-9.
38. Wolthers OD, Pedersen S. Short term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate. Arch Dis Child 1993;68:673 6.
39. Agertoft L, Pedersen S, Relationship between short term lower leg growth and long term statural growth in asthmatic children treated with budesonide. Eur Respir J 1996; 9(Suppl 23):294S.
40. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373 81.
41. Agertoft L, Pedersen S. Bone, growth and collagen markers in children treated with fluticasone propionate and budesonide. Eur Respir J 1996;9(Suppl 23):295S.
42. Todd G, Dunlop K, McNaboe J, Ryan MF, Carson D, Shields MD. Growth and adrenal suppression in asthmatic children treated with high dose fluticasone propionate. Lancet 1996;348:27-9.
43. Allen DB, Mullen M, Mullen B. A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol 1994;93:967-76.
44. Merkus PJFM, van Essen-Zandvliet EM, Durverman EG, van Houwelingen HC, Kerrebijn KF, Quanjer PH. Long term effect of inhaled corticosteroids on growth rate in adolescents with asthma. Paediatrics 1993;6:1121 6.
45. Balfour-Lynn L. Growth and childhood asthma. Arch Dis Child 1986;61:1049-55.
46. Martin AJ, Landau LI, Phelan PD. The effect on growth of childhood asthma. Acta Paediatr Scand 1981;70:683 8.
47. Crowley S, Hindmarsh PC, Mathews DR, Brook CGD. Growth and the growth hormone axis in prepubertal children with asthma. J Pediatr 1995;1:297 303.
48. American College of Rheumatology Task Force on Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 1996;39:1791-801.
49. British Thoracic Society, National Asthma Campaign, Royal College of Physicians of London, et al. The British guidelines on asthma management: 1995 review and position statement. Thorax 1997;52(Suppl 1):S1 21.